Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03422718
Other study ID # HUM00138470
Secondary ID R01MD011516
Status Completed
Phase N/A
First received
Last updated
Start date March 25, 2019
Est. completion date April 8, 2021

Study information

Verified date May 2024
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates a health theory based mobile health behavioral intervention to reduce blood pressure (BP) among hypertensive patients evaluated in a community Emergency Department (ED) setting.


Description:

Hypertension is the most important modifiable risk factor for cardiovascular disease, the leading cause of mortality in the United States. African Americans have the highest prevalence of hypertension of any race/ethnic group in the United States which largely contributes to their increased burden of stroke compared to non-Hispanic whites. In addition, uncontrolled hypertension is more common among socioeconomically disadvantaged populations than their counterparts. To improve health equity, new approaches to hypertension treatment focusing on health care systems and difficult-to-reach populations are needed. The Emergency Department (ED) represents a missed opportunity to identify and treat hypertension in difficult-to-reach populations. Currently, there are 136 million ED visits per year and nearly all have at least one blood pressure measured and recorded. African Americans and socioeconomically disadvantaged patients are disproportionally represented in the ED patient population and both are increasing. In the age of electronic health records and mobile health, the ED can feasibly become an integral partner in chronic disease management by programming the electronic health record to identify hypertensive patients and dispense a mobile health behavioral intervention. Facilitating ED follow up at primary care clinics is a key feature of the proposed intervention. Thereby leveraging the strengths of the ED and its large patient volume of uncontrolled, difficult-to-reach, hypertensive patients, with the strengths of the primary care clinics, continuity of care is the key to improving community wide utilization of health services and receipt of guideline concordant medical care. This study looks to determine which behavioral intervention components best contribute to a reduction in systolic blood pressure at one year through a multi-component theory based mobile health behavioral intervention. Sample Size and Population We originally planned to enroll approximately 960 patients into the eligibility phase. From this group, we estimate that 480 participants will report qualifying BPs and will be randomized to one of the eight intervention arms. We anticipate 240 participants will fully complete the 12 month, in person follow up visits. However, after accruing approximately 400 randomized participants, we noted lower than expected retention at 6 month visits. Therefore, we adjusted the maximum total number of enrollments and randomizations upwards by 50% each. The overall intention is to achieve approximately 240 protocol completers (attendees at 12-month visit). We will continue to monitor accrual and retention in order to achieve this target. Data Analysis The primary analysis will fit a linear regression model with the outcome of SBP change (baseline minus 12 months) and main effect-coded binary predictors of healthy behavior texts (yes vs. no), prompted BP self-monitoring frequency (high vs. low), and primary care provider visit scheduling and transportation (active vs. passive). Initial analyses will focus on the main effects. Additional analyses will include all the two-way interactions of the three intervention components (only considering interactions where at least one of the factors in the interaction demonstrates a sufficiently large main effect). The main secondary analyses will use time-to event (Cox Proportional Hazards) and logistic regression. For the endpoint of interest, (either time to first primary care visit, or the binary variable indicating attendance at two or more primary care visits within 1 year of randomization), the investigators will fit an adjusted regression model. Extension Study: Reach Out Cognition which will extend Reach Out data collection past the current 12 months to 15 and 18 months. During Reach Out Cognition, we aim to assess novel approaches to mobile health (mHealth) self-administered cognition and blood pressure (BP) measurements. These approaches may include cognitive assessments via mobile applications (apps) and Web-based surveys, and wireless BP measurements via Bluetooth-enabled blood pressure cuffs and apps. The study population for Reach Out Cognition will be drawn from Reach Out participants who complete the Reach Out intervention and are defined as: participants who complete the 12-month outcome assessment. We anticipate about 240 participants will have completed Reach Out's 12-month outcome assessment and will be eligible for Reach Out Cognition. Descriptive statistics will be used to evaluate acceptability, feasibility and satisfaction. The de-nominator is the number of Reach Out participants who complete the 12 month assessments. Regarding feasibility, we will separately determine the feasibility by mHealth measure (i.e. cognition vs. BP), phone type (i.e. smartphone vs. feature phone) and operating system type (iOS vs. Android vs. Windows) as a continuous and dichotomous (>50% completion of each assessment type) measure. The satisfaction scale will be assessed for all participants. Given the difference in procedures by phone type, we will compare satisfaction between the smartphone and feature phone users using a Kruskal-Wallis test.


Recruitment information / eligibility

Status Completed
Enrollment 488
Est. completion date April 8, 2021
Est. primary completion date April 8, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age of 18 or greater - At least one BP with Systolic Blood Pressure (SBP) = 160 or a Diastolic Blood Pressure (DBP) = 100 (criteria 1) - If the patient has repeated measurements after achieving Criteria 1, at least one of the repeat BP remains SBP = 140 or a DBP = 90 - Must have cell phones with text-messaging capability and willingness to receive texts - Likely to be discharged from the ED Exclusion Criteria: - Unable to read English (<1% at study site) - Prisoners - Pregnant - Pre-existing condition making one year follow-up unlikely - Terminal illness with death expected within 90 days - Current use of 3 or more antihypertensive agents - Patients with other serious medical conditions that prevent self-monitoring of BP - Critical illness with placement in resuscitation bay - Dementia/cognitive impairment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Healthy Behavior Texts
Participants receive motivational health behavior texts
No healthy behavior texts
Participants do not receive healthy behavior texts
BP Monitoring Daily Via Text Messaging
Daily text messages will prompt participants for BP by home cuff
BP Monitoring Weekly Via Text Messaging
Weekly text messages will prompt participants for BP by home cuff
Physician appointment and transportation scheduling
Participants receive assistance scheduling physician appointment and transportation to those appointments
No physician appointment and transportation scheduling
Participants do not receive assistance scheduling physician appointment or transportation

Locations

Country Name City State
United States Hurley Medical Center Flint Michigan

Sponsors (3)

Lead Sponsor Collaborator
University of Michigan National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Mean Systolic Blood Pressure Change in 12-month Systolic Blood Pressure (SBP) 12 months
Secondary Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP Visit Utilizing multivariable Cox regression analysis, the relationship between mHealth components and attendance at initial Primary Care Physician (PCP) appointment after Emergency Department visit is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Hazard Ratio in this context is a measure indicating the relative risk of experiencing the event of interest (time to first PCP visit). A Hazard Ratio greater than 1 implies a greater risk of receipt of a first PCP appointment, and a Hazard Ratio less than 1 implies a lower risk of receipt of a first PCP appointment within 12-month follow-up. The use of Hazard Ratio in this context allows for the assessment of the impact of mHealth components on the timing of primary care engagement while accounting for potential confounding variables. This allows more valuable insights into the effectiveness of these components in facilitating access to primary care visits. Baseline ED visit (in days)
Secondary Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits Utilizing logistic regression analysis, the probability of participants attending 2 or more primary care visits within a 12-month period is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Odds Ratio in this context indicates the likelihood of an event occurring. A higher Odds Ratio suggests an increased likelihood of attending multiple primary care visits, while a lower Odds Ratio indicates a decreased likelihood. The use of Odds Ratio in this context is justified as it allows for the comparison of the likelihood of attending two or more primary care while accounting for covariates. This is useful in logistic regression analysis, where the outcome variable is binary (i.e., attending two or more primary care visits or not) and the focus is on understanding the association between predictor variables and the probability of the outcome. 12 months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A